Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma.
作者信息
Richardson Paul G, Facon Thierry, Bensinger William I, Leleu Xavier, Campana Frank, Macé Sandrine, Chiron Marielle, van de Velde Helgi, Mikhael Joseph
机构信息
Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Department of Haematology, Lille University Hospital, Lille, France.
出版信息
Blood Cancer J. 2021 Mar 12;11(3):55. doi: 10.1038/s41408-021-00438-y.
Abstract
摘要
Zotero 插件